Sorrento Therapeutics, Inc.'s Net Worth
Estimate Recalculated May 7, 2026 01:33PM EST
Who is Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. has an estimated net worth of $17.8 Million. This is based on reported shares across multiple companies, which include Celularity Inc, and Scilex Holding Co.
SEC CIK
Sorrento Therapeutics, Inc.'s CIK is 0000850261
Past Insider Trading and Trends
2022 was Sorrento Therapeutics, Inc.'s most active year for acquiring shares with 6 total transactions. Sorrento Therapeutics, Inc.'s most active month to acquire stocks was the month of October. 2023 was Sorrento Therapeutics, Inc.'s most active year for disposing of shares, totalling 5 transactions. Sorrento Therapeutics, Inc.'s most active month to dispose stocks was the month of August. 2022 saw Sorrento Therapeutics, Inc. paying a total of $426,764.78 for 4,490,617 shares, this is the most they've acquired in one year. In 2023 Sorrento Therapeutics, Inc. cashed out on 153,671,694 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
